HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael J Ausserlechner Selected Research

3- cyclopropylmethyl- 7- phenyl- 3H- pyrrolo(3,2- f)quinolin- 9(6H)- one

5/2017The tubulin inhibitor MG-2477 induces autophagy-regulated cell death, ROS accumulation and activation of FOXO3 in neuroblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael J Ausserlechner Research Topics

Disease

15Neoplasms (Cancer)
12/2022 - 07/2008
11Neuroblastoma
12/2022 - 03/2010
3Neoplasm Metastasis (Metastasis)
12/2022 - 06/2012
3Leukemia
01/2014 - 11/2009
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
07/2013 - 11/2009
1Chronic Pain
01/2022
1Ovarian Neoplasms (Ovarian Cancer)
01/2022
1Colonic Neoplasms (Colon Cancer)
01/2021
1Trifunctional Protein Deficiency With Myopathy And Neuropathy
01/2021
1Wounds and Injuries (Trauma)
10/2019
1Hyperglycemia
01/2019
1VLCAD deficiency
01/2018
1Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
01/2018
1Muscle Weakness
01/2018
1Inborn Genetic Diseases (Disease, Hereditary)
01/2018
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
07/2013
1T-Cell Leukemia (Leukemia, T Cell)
11/2009
1Osteosarcoma (Osteogenic Sarcoma)
07/2008
1Autosomal Recessive Polycystic Kidney (Polycystic Kidney Disease, Infantile, Type I)
05/2006

Drug/Important Bio-Agent (IBA)

6Pharmaceutical PreparationsIBA
12/2022 - 01/2014
3Glucose (Dextrose)FDA LinkGeneric
01/2021 - 01/2018
3Transcription Factors (Transcription Factor)IBA
01/2020 - 09/2014
3Proteins (Proteins, Gene)FDA Link
01/2019 - 08/2013
3Apoptosis Regulatory ProteinsIBA
01/2014 - 03/2010
2Reactive Oxygen Species (Oxygen Radicals)IBA
10/2019 - 09/2014
2CaspasesIBA
01/2019 - 01/2014
2SurvivinIBA
01/2019 - 03/2016
2X-Linked Inhibitor of Apoptosis ProteinIBA
01/2014 - 01/2014
2Caspase 8 (Caspase-8)IBA
01/2014 - 06/2012
1Opioid Analgesics (Opioids)IBA
01/2022
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022
1Methadone (Dolophine)FDA LinkGeneric
01/2022
1mu Opioid Receptors (mu Opioid Receptor)IBA
01/2022
1Analgesics (Analgesic Drugs)IBA
01/2022
1SphingomyelinsIBA
01/2021
1CeramidesIBA
01/2021
1Deoxyglucose (2 Deoxy D glucose)IBA
01/2021
1CarbenoxoloneIBA
01/2020
1repaglinide (Prandin)FDA Link
12/2019
1LumicanIBA
12/2019
1OxalatesIBA
12/2019
1SaltsIBA
12/2019
1CalciumIBA
10/2019
1Mitochondrial Trifunctional ProteinIBA
01/2018
1Fatty Acids (Saturated Fatty Acids)IBA
01/2018
1Tubulin ModulatorsIBA
05/2017
13- cyclopropylmethyl- 7- phenyl- 3H- pyrrolo(3,2- f)quinolin- 9(6H)- oneIBA
05/2017
1DNA (Deoxyribonucleic Acid)IBA
11/2016
1Caspase 9IBA
01/2014
1Inhibitor of Apoptosis ProteinsIBA
01/2014
1Etoposide (VP 16)FDA LinkGeneric
01/2014
1Prednisone (Sone)FDA LinkGeneric
07/2013
1Forkhead Box Protein O3IBA
07/2013
1DecitabineFDA Link
06/2012
1LigandsIBA
06/2012
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2012
1Bortezomib (Velcade)FDA Link
03/2010
1Proteasome InhibitorsIBA
03/2010
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
11/2009
1Proto-Oncogene Proteins c-bcl-2 (Proto Oncogene Proteins c bcl 2)IBA
11/2009
1Cyclin-Dependent Kinase Inhibitor p16IBA
11/2009
1Small Interfering RNA (siRNA)IBA
11/2009
1GlucocorticoidsIBA
11/2009
1Pyruvate KinaseIBA
07/2008
1PhosphoenolpyruvateIBA
07/2008
1IsoenzymesIBA
07/2008
1Peptide AptamersIBA
07/2008

Therapy/Procedure

9Therapeutics
01/2020 - 06/2012
1Precision Medicine
12/2022
1Drug Therapy (Chemotherapy)
01/2019
1Transplantation
05/2006
1Nephrectomy
05/2006